I am an investor relations consultant with 25+ years experience steering IR strategy and outreach for over 100 companies across a range of industries. We launched Catalyst Global in early 2012 to serve as a platform for innovating the IR role to better address the radically different dynamics and needs of public companies and investors.
Catalyst's mission is combining senior level experience and counsel with targeted outreach and efficient communications to deliver real change and share price results for "smidcap" companies in today's markets. We understand relationships and credibility take time, and we root all our work in integrity, candor and a focus on ROI.
I post on Seeking Alpha to expand the reach of client and other investment stories we like - and to understand the nature of these new channels of communication. Networking ideas and working with new media is integral to the IR function - plus it's fun.
CG Focus List is a separate service we use to highlight specific investment stories brought to us by some of the really smart investors we know. Profiled companies can be clients, ex-clients, non-clients or desired clients - but they are stories that offer very attractive investment potential and commensurate risk (there's no free ride in investing!)
My posts are NOT endorsed by the Companies on which I write - client or otherwise. We believe in truth and fair play at all times, and at all costs, and gravitate to those who share that view.
I joined Seeking Alpha in February 2014 as editor of the biotech vertical. In addition to onboarding new contributors, my job is to make sure Seeking Alpha provides high-quality and comprehensive coverage of the biotechnology and health care sectors. I am always looking for new ideas, so please reach out if you're interested.